{"title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","uri":"","abstract":"Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in individuals who develop high titers of anti-ZIKV antibodies, we screened cohorts in Brazil and Mexico for ZIKV envelope domain III (ZEDIII) binding and neutralization. We find that serologic reactivity to dengue 1 virus (DENV1) EDIII before ZIKV exposure is associated with increased ZIKV neutralizing titers after exposure. Antibody cloning shows that donors with high ZIKV neutralizing antibody titers have expanded clones of memory B cells that express the same immunoglobulin VH3-23/VK1-5 genes. These recurring antibodies cross-react with DENV1, but not other flaviviruses, neutralize both DENV1 and ZIKV, and protect mice against ZIKV challenge. Structural analyses reveal the mechanism of recognition of the ZEDIII lateral ridge by VH3-23/VK1-5 antibodies. Serologic testing shows that antibodies to this region correlate with serum neutralizing activity to ZIKV. Thus, high neutralizing responses to ZIKV are associated with pre-existing reactivity to DENV1 in humans.","documents":[{"id":"http://authors.library.caltech.edu/id/document/252195","docid":252195,"rev_number":3,"files":[{"id":"http://authors.library.caltech.edu/id/file/1257292","fileid":1257292,"datasetid":"document","objectid":252195,"filename":"PIIS0092867417304750.pdf","mime_type":"application/pdf","hash":"f7a04f099a13784bfec5c6d022ecb413","hash_type":"MD5","filesize":6078152,"mtime":"2017-05-15 16:56:10","url":"http://authors.library.caltech.edu/77442/1/PIIS0092867417304750.pdf"}],"eprintid":77442,"pos":1,"placement":1,"mime_type":"application/pdf","format":"application/pdf","language":"en","security":"internal","license":"other","main":"PIIS0092867417304750.pdf","content":"published"},{"id":"http://authors.library.caltech.edu/id/document/252197","docid":252197,"rev_number":2,"files":[{"id":"http://authors.library.caltech.edu/id/file/1257306","fileid":1257306,"datasetid":"document","objectid":252197,"filename":"mmc1.pdf","mime_type":"application/pdf","hash":"1d2e5b5e915fa263d897cdfc930d1cad","hash_type":"MD5","filesize":120978,"mtime":"2017-05-15 17:17:31","url":"http://authors.library.caltech.edu/77442/2/mmc1.pdf"}],"eprintid":77442,"pos":2,"placement":2,"mime_type":"application/pdf","format":"application/pdf","language":"en","security":"public","license":"other","main":"mmc1.pdf","content":"supplemental"},{"id":"http://authors.library.caltech.edu/id/document/252198","docid":252198,"rev_number":2,"files":[{"id":"http://authors.library.caltech.edu/id/file/1257308","fileid":1257308,"datasetid":"document","objectid":252198,"filename":"mmc2.xlsx","mime_type":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","hash":"eb38175e10a747f95ba4e49c8f6aa1ca","hash_type":"MD5","filesize":63121,"mtime":"2017-05-15 17:17:39","url":"http://authors.library.caltech.edu/77442/3/mmc2.xlsx"}],"eprintid":77442,"pos":3,"placement":3,"mime_type":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","format":"application/vnd.ms-excel","language":"en","security":"public","license":"other","main":"mmc2.xlsx","content":"supplemental"},{"id":"http://authors.library.caltech.edu/id/document/252199","docid":252199,"rev_number":2,"files":[{"id":"http://authors.library.caltech.edu/id/file/1257310","fileid":1257310,"datasetid":"document","objectid":252199,"filename":"mmc3.xlsx","mime_type":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","hash":"0418eebec7eae5d1e0e17acc8e6c767a","hash_type":"MD5","filesize":30031,"mtime":"2017-05-15 17:17:46","url":"http://authors.library.caltech.edu/77442/4/mmc3.xlsx"}],"eprintid":77442,"pos":4,"placement":4,"mime_type":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","format":"application/vnd.ms-excel","language":"en","security":"public","license":"other","main":"mmc3.xlsx","content":"supplemental"}],"note":"© 2017 Elsevier Inc. \n\nReceived 3 April 2017, Revised 17 April 2017, Accepted 17 April 2017, Available online 4 May 2017. \n\nWe would especially like to thank the members of the Santa Maria Mixtequilla and Pau da Lima communities who agreed to participate in this study, as well as the Fiocruz community research team and staff of Hospital Geral Roberto Santos for their assistance with the clinical protocols. We thank members of the Nussenzweig and Rice labs for helpful discussions and suggestions. A particular thank you to Lotta von Boehmer, Christian Mayer, Yotam Bar-On, Irina Shimeliovich, and Julio Cetrulo Lorenzi for sharing expertise, protocols, and reagents. We thank Ted Pierson for plasmids pWNVII-Rep-REN-IB and pZIKV/HPF/CprME, Aaron Brault (CDC) for ZIKV PRVABC59, Bob Tesh for DENV1 PUO-359, Matt Evans for ZIKV MR766 cDNA, and Greg Ebel, James Weger, and Brian Geiss for ZIKV PRVABC59 cDNA. We are grateful to Laura Kramer (NYSDOH) and Robert Lanciotti (CDC) for PRNT advice and protocols, Kimberly Dowd for RVP advice, and Muhammad Arshad for cloning assistance. We thank Barbara Johnson, Ann Powers, Christin Goodman, Claire Huang, Brandy Russell (CDC), and Claudia Duarte dos Santos for sharing ZIKV information early on. Moreover, we are thankful to Mary Ellen Castillo for facilitating virus work in the cell culture core, Alison Ashbrook for help with PRNT assays, Natalia Frias-Staheli for generation of the DENV1 stock, Corrine Quirk for assistance with mouse colonies, Tiffany Luong, Alisa Voll, and the Caltech Protein Expression Center for cloning, expression, and purification of proteins for crystallography, and Christopher Barnes and Beth Stadtmueller for help with crystallographic methods. This work was supported by NIH pilot awards U19AI111825 (to D.F.R.) and UL1TR001866 (to D.F.R. and L.B.), grants R01AI037526, UM1AI100663, U19AI111825, and UL1TR001866 (to M.C.N.), grants R01AI121207, R01TW009504, R25TW009338, and U01AI088752 (to A.I.K.), grants R01AI124690 (to C.M.R.) and U19AI057229 (CCHI Opportunity Fund Project to C.M.R. and M.R.M.), donors to the Zika Fund at Rockefeller University and anonymous donors (to C.M.R.), and the Molecular Observatory at Caltech supported by the Gordon and Betty Moore Foundation (P.J.B.). Operations at the Stanford Synchrotron Radiation Lightsource are supported by the US Department of Energy and the NIH. Support was also provided by the Robertson Therapeutic Development Fund (to D.F.R. and M.C.N.). P.C.O. is supported by the Pew Latin American Fellows Program in the Biomedical Sciences, D.S.-B. by Studienstiftung des deutschen Volkes, L.F.K.U. by the Austrian Marshall Plan Foundation, and E.E.S.-R. is partly supported by Red INMUNOCANEI-Conacyt. M.C.N. is an HHMI Investigator. In connection with this work, D.F.R. and M.C.N. have a provisional patent application with the U.S. Patent and Trademark Office (62/483,001). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies or individuals.","id":77442,"rev_number":19,"userid":772,"eprint_dir":"disk0/00/07/74/42","datestamp":"2017-05-16 02:37:10","lastmod":"2017-05-16 02:37:10","status_changed":"2017-05-16 02:37:10","type":"article","metadata_visibility":"show","creators":[{"given":"Davide F.","family":"Robbiani","id":"Robbiani-D-F","orcid":""},{"given":"Ricardo","family":"Khouri","id":"Khouri-R","orcid":""},{"given":"Harry B.","family":"Gristick","id":"Gristick-H-B","orcid":""},{"given":"Yu E.","family":"Lee","id":"Lee-Yu-E","orcid":""},{"given":"Anthony P., Jr.","family":"West","id":"West-A-P-Jr","orcid":""},{"given":"Pamela J.","family":"Bjorkman","id":"Bjorkman-P-J","orcid":"0000-0002-2277-3990"}],"ispublished":"pub","subjects":null,"full_text_status":"public","keywords":"Zika virus; dengue virus; flavivirus; antibodies; vaccine; structure","date":"2017-05-04","date_type":"published","publication":"Cell","volume":"169","number":"4","pagerange":"597-609","id_number":"CaltechAUTHORS:20170515-095254627","refereed":true,"issn":"0092-8674","official_url":"http://resolver.caltech.edu/CaltechAUTHORS:20170515-095254627","related_url":[{"url":"https://doi.org/10.1016/j.cell.2017.04.024","type":"doi","description":"Article"},{"url":"http://www.sciencedirect.com/science/article/pii/S0092867417304750","type":"pub","description":"Article"}],"referencetext":["Adams, P.D., Afonine, P.V., Bunko´ czi, G., Chen, V.B., Davis, I.W., Echols, N.,\nHeadd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010).\nPHENIX: a comprehensive Python-based system for macromolecular structure\nsolution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221.\nArnaout, R., Lee, W., Cahill, P., Honan, T., Sparrow, T., Weiand, M., Nusbaum,\nC., Rajewsky, K., and Koralov, S.B. (2011). High-resolution description of antibody\nheavy-chain repertoires in humans. PLoS ONE 6, e22365.\nBarba-Spaeth, G., Dejnirattisai, W., Rouvinski, A., Vaney, M.C., Medits, I.,\nSharma, A., Simon-Lorie` re, E., Sakuntabhai, A., Cao-Lormeau, V.M., Haouz,\nA., et al. (2016). Structural basis of potent Zika-dengue virus antibody crossneutralization.\nNature 536, 48–53.\nBardina, S.V., Bunduc, P., Tripathi, S., Duehr, J., Frere, J.J., Brown, J.A.,\nNachbagauer, R., Foster, G.A., Krysztof, D., Tortorella, D., et al. (2017).\nEnhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.\nScience 356, 175–180.\nBarzon, L., Pacenti, M., Franchin, E., Lavezzo, E., Trevisan, M., Sgarabotto, D.,\nand Palu, G. (2016). Infection dynamics in a traveller with persistent shedding\nof Zika virus RNA in semen for six months after returning from Haiti to Italy,\nJanuary 2016. Euro. Surveill 21.\nBattye, T.G., Kontogiannis, L., Johnson, O., Powell, H.R., and Leslie, A.G.\n(2011). iMOSFLM: a new graphical interface for diffraction-image processing\nwith MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67, 271–281.\nBeasley, D.W., and Barrett, A.D. (2002). Identification of neutralizing epitopes\nwithin structural domain III of the West Nile virus envelope protein. J. Virol. 76,\n13097–13100.\nBlight, K.J., McKeating, J.A., and Rice, C.M. (2002). Highly permissive cell lines\nfor subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76,\n13001–13014.\nBrasil, P., Pereira, J.P., Jr., Moreira, M.E., Ribeiro Nogueira, R.M., Damasceno,\nL., Wakimoto, M., Rabello, R.S., Valderramos, S.G., Halai, U.A., Salles, T.S.,\net al. (2016). Zika Virus Infection in Pregnant Women in Rio de Janeiro.\nN. Engl. J. Med. 375, 2321–2334.\nCardoso, C.W., Paploski, I.A., Kikuti, M., Rodrigues, M.S., Silva, M.M., Campos,\nG.S., Sardi, S.I., Kitron, U., Reis, M.G., and Ribeiro, G.S. (2015). Outbreak\nof Exanthematous Illness Associated with Zika, Chikungunya, and Dengue\nViruses, Salvador, Brazil. Emerg. Infect. Dis. 21, 2274–2276.\nCastanha, P.M., Nascimento, E.J., Cynthia, B., Cordeiro, M.T., de Carvalho,\nO.V., de Mendonc¸ a, L.R., Azevedo, E.A., Franc¸ a, R.F., Rafael, D., and Marques,\nE.T., Jr. (2016). Dengue virus (DENV)-specific antibodies enhance Brazilian\nZika virus (ZIKV) infection. J. Infect. Dis. 215, 781–785.\nChapgier, A., Boisson-Dupuis, S., Jouanguy, E., Vogt, G., Feinberg, J., Prochnicka-\nChalufour, A., Casrouge, A., Yang, K., Soudais, C., Fieschi, C., et al.\n(2006). Novel STAT1 alleles in otherwise healthy patients with mycobacterial\ndisease. PLoS Genet. 2, e131.\nCosta, F., Sarno, M., Khouri, R., de Paula Freitas, B., Siqueira, I., Ribeiro, G.S.,\nRibeiro, H.C., Campos, G.S., Alcaˆ ntara, L.C., Reis, M.G., et al. (2016). Emergence\nof Congenital Zika Syndrome: Viewpoint From the Front Lines. Ann.\nIntern. Med. 164, 689–691.\nCrill, W.D., and Roehrig, J.T. (2001). Monoclonal antibodies that bind to\ndomain III of dengue virus E glycoprotein are the most efficient blockers of\nvirus adsorption to Vero cells. J. Virol. 75, 7769–7773.\nDai, L., Song, J., Lu, X., Deng, Y.Q., Musyoki, A.M., Cheng, H., Zhang, Y.,\nYuan, Y., Song, H., Haywood, J., et al. (2016). Structures of the Zika Virus Envelope\nProtein and Its Complex with a Flavivirus Broadly Protective Antibody.\nCell Host Microbe 19, 696–704.\nDejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G.,\nDuangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.M., Malasit, P., Rey, F.A.,\net al. (2016). Dengue virus sero-cross-reactivity drives antibody-dependent\nenhancement of infection with zika virus. Nat. Immunol. 17, 1102–1108.\nDeKosky, B.J., Kojima, T., Rodin, A., Charab, W., Ippolito, G.C., Ellington,\nA.D., and Georgiou, G. (2015). In-depth determination and analysis of the human\npaired heavy- and light-chain antibody repertoire. Nat. Med. 21, 86–91.\nEkiert, D.C., Bhabha, G., Elsliger, M.A., Friesen, R.H., Jongeneelen, M.,\nThrosby, M., Goudsmit, J., and Wilson, I.A. (2009). Antibody recognition of a\nhighly conserved influenza virus epitope. Science 324, 246–251.\nEmsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular\ngraphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132.\nEscolano, A., Dosenovic, P., and Nussenzweig, M.C. (2017). Progress toward\nactive or passive HIV-1 vaccination. J. Exp. Med. 214, 3–16.\nFelzemburgh, R.D., Ribeiro, G.S., Costa, F., Reis, R.B., Hagan, J.E., Melendez,\nA.X., Fraga, D., Santana, F.S., Mohr, S., dos Santos, B.L., et al. (2014). Prospective\nstudy of leptospirosis transmission in an urban slum community:\nrole of poor environment in repeated exposures to the Leptospira agent.\nPLoS Negl. Trop. Dis. 8, e2927.\nFoy, B.D., Kobylinski, K.C., Chilson Foy, J.L., Blitvich, B.J., Travassos da\nRosa, A., Haddow, A.D., Lanciotti, R.S., and Tesh, R.B. (2011). Probable\nnon-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect.\nDis. 17, 880–882.\nFranc¸ a, G.V., Schuler-Faccini, L., Oliveira, W.K., Henriques, C.M., Carmo,\nE.H., Pedi, V.D., Nunes, M.L., Castro, M.C., Serruya, S., Silveira, M.F., et al.\n(2016). Congenital Zika virus syndrome in Brazil: a case series of the first\n1501 livebirths with complete investigation. Lancet 388, 891–897.\nHagan, J.E., Moraga, P., Costa, F., Capian, N., Ribeiro, G.S., Wunder, E.A., Jr.,\nFelzemburgh, R.D., Reis, R.B., Nery, N., Santana, F.S., et al. (2016). Spatiotemporal\nDeterminants of Urban Leptospirosis Transmission: Four-Year Prospective\nCohort Study of Slum Residents in Brazil. PLoS Negl. Trop. Dis. 10,\ne0004275.\nHarrison, S.C. (2016). Immunogenic cross-talk between dengue and Zika viruses.\nNat. Immunol. 17, 1010–1012.\nHeinz, F.X., and Stiasny, K. (2017). The antigenic structure of Zika virus and its\nrelation to other flaviviruses: implications for infection and immunoprophylaxis.\nMicrobiology and molecular biology reviews. Microbiol. Mol. Biol. Rev. 81,\ne00055–16.\nHenchal, E.A., Gentry, M.K., McCown, J.M., and Brandt, W.E. (1982). Dengue\nvirus-specific and flavivirus group determinants identified with monoclonal antibodies\nby indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31, 830–836.\nHonein, M.A., Dawson, A.L., Petersen, E.E., Jones, A.M., Lee, E.H., Yazdy,\nM.M., Ahmad, N., Macdonald, J., Evert, N., Bingham, A., et al.; US Zika\nPregnancy Registry Collaboration (2017). Birth Defects Among Fetuses and\nInfants of US Women With Evidence of Possible Zika Virus Infection During\nPregnancy. JAMA 317, 59–68.\nJones, T.A. (2004). Interactive electron-density map interpretation: from INTER\nto O. Acta Crystallogr. D Biol. Crystallogr. 60, 2115–2125.\nKlein, F., Nogueira, L., Nishimura, Y., Phad, G., West, A.P., Jr., Halper-Stromberg,\nA., Horwitz, J.A., Gazumyan, A., Liu, C., Eisenreich, T.R., et al. (2014).\nEnhanced HIV-1 immunotherapy by commonly arising antibodies that target\nvirus escape variants. J. Exp. Med. 211, 2361–2372.\nKostyuchenko, V.A., Lim, E.X., Zhang, S., Fibriansah, G., Ng, T.S., Ooi, J.S.,\nShi, J., and Lok, S.M. (2016). Structure of the thermally stable Zika virus.\nNature 533, 425–428.\nKramer, L.D., Li, J., and Shi, P.Y. (2007). West Nile virus. Lancet Neurol. 6,\n171–181.\nLanciotti, R.S., Lambert, A.J., Holodniy, M., Saavedra, S., and Signor, Ldel.C.\n(2016). Phylogeny of Zika Virus in Western Hemisphere, 2015. Emerg. Infect.\nDis. 22, 933–935.\nLaursen, N.S., and Wilson, I.A. (2013). Broadly neutralizing antibodies against\ninfluenza viruses. Antiviral Res. 98, 476–483.\nLessler, J., Chaisson, L.H., Kucirka, L.M., Bi, Q., Grantz, K., Salje, H., Carcelen,\nA.C., Ott, C.T., Sheffield, J.S., Ferguson, N.M., et al. (2016). Assessing the\nglobal threat from Zika virus. Science 353, aaf8160.\nLi, M.Z., and Elledge, S.J. (2007). Harnessing homologous recombination\nin vitro to generate recombinant DNA via SLIC. Nat. Methods 4, 251–256.\nMiner, J.J., and Diamond, M.S. (2017). Zika Virus Pathogenesis and Tissue\nTropism. Cell Host Microbe 21, 134–142.\nModis, Y., Ogata, S., Clements, D., and Harrison, S.C. (2003). A ligand-binding\npocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA\n100, 6986–6991.\nMouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J.F., Halper-Stromberg,\nA., Gnanapragasam, P.N., Spencer, D.I., Seaman, M.S., et al. (2012).\nComplex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.\nProc. Natl. Acad. Sci. USA 109, E3268–E3277.\nMukherjee, S., Pierson, T.C., and Dowd, K.A. (2014). Pseudo-infectious reporter\nvirus particles for measuring antibody-mediated neutralization and\nenhancement of dengue virus infection. Methods Mol. Biol. 1138, 75–97.\nMukhopadhyay, S., Kuhn, R.J., and Rossmann, M.G. (2005). A structural\nperspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3, 13–22.\nMurray, N.E., Quam, M.B., and Wilder-Smith, A. (2013). Epidemiology of\ndengue: past, present and future prospects. Clin. Epidemiol. 5, 299–309.\nMurray, K.O., Gorchakov, R., Carlson, A.R., Berry, R., Lai, L., Natrajan, M.,\nGarcia, M.N., Correa, A., Patel, S.M., Aagaard, K., and Mulligan, M.J. (2017).\nProlonged Detection of Zika Virus in Vaginal Secretions and Whole Blood.\nEmerg. Infect. Dis. 23, 99–101.\nPappas, L., Foglierini, M., Piccoli, L., Kallewaard, N.L., Turrini, F., Silacci, C.,\nFernandez-Rodriguez, B., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G.,\net al. (2014). Rapid development of broadly influenza neutralizing antibodies\nthrough redundant mutations. Nature 516, 418–422.\nPierson, T.C., and Graham, B.S. (2016). Zika Virus: Immunity and Vaccine\nDevelopment. Cell 167, 625–631.\nPierson, T.C., Sa´ nchez, M.D., Puffer, B.A., Ahmed, A.A., Geiss, B.J., Valentine,\nL.E., Altamura, L.A., Diamond, M.S., and Doms, R.W. (2006). A rapid and quantitative\nassay for measuring antibody-mediated neutralization of West Nile\nvirus infection. Virology 346, 53–65.\nPriyamvada, L., Quicke, K.M., Hudson, W.H., Onlamoon, N., Sewatanon, J.,\nEdupuganti, S., Pattanapanyasat, K., Chokephaibulkit, K., Mulligan, M.J.,\nWilson, P.C., et al. (2016). Human antibody responses after dengue virus infection\nare highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. USA 113,\n7852–7857.\nRey, F.A., Heinz, F.X., Mandl, C., Kunz, C., and Harrison, S.C. (1995). The envelope\nglycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature\n375, 291–298.\nRubelt, F., Sievert, V., Knaust, F., Diener, C., Lim, T.S., Skriner, K., Klipp, E.,\nReinhardt, R., Lehrach, H., and Konthur, Z. (2012). Onset of immune senescence\ndefined by unbiased pyrosequencing of human immunoglobulin\nmRNA repertoires. PLoS ONE 7, e49774.\nSabin, A.B. (1950). The dengue group of viruses and its family relationships.\nBacteriol. Rev. 14, 225–232.\nSabin, A.B. (1952). Research on dengue during World War II. Am. J. Trop. Med.\nHyg. 1, 30–50.\nSapparapu, G., Fernandez, E., Kose, N., Bin Cao, Fox, J.M., Bombardi, R.G.,\nZhao, H., Nelson, C.A., Bryan, A.L., Barnes, T., et al. (2016). Neutralizing human\nantibodies prevent Zika virus replication and fetal disease in mice. Nature\n540, 443–447.\nScheid, J.F., Mouquet, H., Feldhahn, N., Walker, B.D., Pereyra, F., Cutrell, E.,\nSeaman, M.S., Mascola, J.R., Wyatt, R.T., Wardemann, H., and Nussenzweig,\nM.C. (2009). A method for identification of HIV gp140 binding memory B cells in\nhuman blood. J. Immunol. Methods 343, 65–67.\nScheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T.Y.,\nPietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011). Sequence and\nstructural convergence of broad and potent HIV antibodies that mimic CD4\nbinding. Science 333, 1633–1637.\nScreaton, G., Mongkolsapaya, J., Yacoub, S., and Roberts, C. (2015). New insights\ninto the immunopathology and control of dengue virus infection. Nat.\nRev. Immunol. 15, 745–759.\nSilva, M.M., Rodrigues, M.S., Paploski, I.A., Kikuti, M., Kasper, A.M., Cruz,\nJ.S., Queiroz, T.L., Tavares, A.S., Santana, P.M., Arau´ jo, J.M., et al. (2016). Accuracy\nof Dengue Reporting by National Surveillance System, Brazil. Emerg.\nInfect. Dis. 22, 336–339.\nSirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T.C., Rossmann, M.G., and\nKuhn, R.J. (2016). The 3.8A ° resolution cryo-EMstructure of Zika virus. Science\n352, 467–470.\nStettler, K., Beltramello, M., Espinosa, D.A., Graham, V., Cassotta, A., Bianchi,\nS., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. (2016). Specificity, crossreactivity,\nand function of antibodies elicited by Zika virus infection. Science\n353, 823–826.\nSui, J., Hwang, W.C., Perez, S., Wei, G., Aird, D., Chen, L.M., Santelli, E., Stec,\nB., Cadwell, G., Ali, M., et al. (2009). Structural and functional bases for broadspectrum\nneutralization of avian and human influenza A viruses. Nat. Struct.\nMol. Biol. 16, 265–273.\nSuy, A., Sulleiro, E., Rodo´ , C., Va´ zquez, E´ ., Bocanegra, C., Molina, I.,\nEsperalba, J., Sa´ nchez-Seco, M.P., Boix, H., Pumarola, T., and Carreras, E.\n(2016). Prolonged Zika Virus Viremia during Pregnancy. N. Engl. J. Med.\n375, 2611–2613.\nSwanstrom, J.A., Plante, J.A., Plante, K.S., Young, E.F., McGowan, E., Gallichotte,\nE.N., Widman, D.G., Heise, M.T., de Silva, A.M., and Baric, R.S.\n(2016). Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated\nfrom Dengue Patients Are Protective against Zika Virus. MBio 7, e01123–16.","Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L.L., Alard, P., Cornelissen,\nL., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008). Heterosubtypic\nneutralizing monoclonal antibodies cross-protective against H5N1\nand H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3, e3942.\nTiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M.C., and Wardemann,\nH. (2008). Efficient generation of monoclonal antibodies from single human\nB cells by single cell RT-PCR and expression vector cloning. J. Immunol.\nMethods 329, 112–124.\nvon Boehmer, L., Liu, C., Ackerman, S., Gitlin, A.D., Wang, Q., Gazumyan, A.,\nand Nussenzweig, M.C. (2016). Sequencing and cloning of antigen-specific\nantibodies from mouse memory B cells. Nat. Protoc. 11, 1908–1923.\nWahala, W.M., and Silva, A.M. (2011). The human antibody response to\ndengue virus infection. Viruses 3, 2374–2395.\nWang, Q., Yang, H., Liu, X., Dai, L., Ma, T., Qi, J., Wong, G., Peng, R., Liu, S., Li,\nJ., et al. (2016). Molecular determinants of human neutralizing antibodies isolated\nfrom a patient infected with Zika virus. Sci. Transl. Med. 8, 369ra179.\nWardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., and Nussenzweig,\nM.C. (2003). Predominant autoantibody production by early human\nB cell precursors. Science 301, 1374–1377.\nWeaver, S.C., and Reisen, W.K. (2010). Present and future arboviral threats.\nAntiviral Res. 85, 328–345.\nWeaver, S.C., Costa, F., Garcia-Blanco, M.A., Ko, A.I., Ribeiro, G.S., Saade,\nG., Shi, P.Y., and Vasilakis, N. (2016). Zika virus: History, emergence, biology,\nand prospects for control. Antiviral Res. 130, 69–80.\nWest, A.P., Jr., Diskin, R., Nussenzweig, M.C., and Bjorkman, P.J. (2012).\nStructural basis for germ-line gene usage of a potent class of antibodies targeting\nthe CD4-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. USA 109,\nE2083–E2090.\nWest, A.P., Jr., Scharf, L., Horwitz, J., Klein, F., Nussenzweig, M.C., and Bjorkman,\nP.J. (2013). Computational analysis of anti-HIV-1 antibody neutralization\npanel data to identify potential functional epitope residues. Proc. Natl. Acad.\nSci. USA 110, 10598–10603.\nWinn, M.D., Ballard, C.C., Cowtan, K.D., Dodson, E.J., Emsley, P., Evans,\nP.R., Keegan, R.M., Krissinel, E.B., Leslie, A.G., McCoy, A., et al. (2011). Overview\nof the CCP4 suite and current developments. Acta Crystallogr. D Biol.\nCrystallogr. 67, 235–242.\nWrammert, J., Koutsonanos, D., Li, G.M., Edupuganti, S., Sui, J., Morrissey,\nM., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W.I., et al. (2011).\nBroadly cross-reactive antibodies dominate the human B cell response\nagainst 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208,\n181–193.\nYe, J., Ma, N., Madden, T.L., and Ostell, J.M. (2013). IgBLAST: an immunoglobulin\nvariable domain sequence analysis tool. Nucleic Acids Res. 41,\nW34–W40.\nYurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual,\nV., and Nussenzweig, M.C. (2005). Defective B cell tolerance checkpoints in\nsystemic lupus erythematosus. J. Exp. Med. 201, 703–711.\nZhang, Y., Zhang, W., Ogata, S., Clements, D., Strauss, J.H., Baker, T.S.,\nKuhn, R.J., and Rossmann, M.G. (2004). Conformational changes of the flavivirus\nE glycoprotein. Structure 12, 1607–1618.\nZhou, T., Georgiev, I., Wu, X., Yang, Z.Y., Dai, K., Finzi, A., Kwon, Y.D., Scheid,\nJ.F., Shi, W., Xu, L., et al. (2010). Structural basis for broad and potent neutralization\nof HIV-1 by antibody VRC01. Science 329, 811–817."],"rights":"No commercial reproduction, distribution, display or performance rights in this work are provided.","official_citation":"Davide F. Robbiani, Leonia Bozzacco, Jennifer R. Keeffe, Ricardo Khouri, Priscilla C. Olsen, Anna Gazumyan, Dennis Schaefer-Babajew, Santiago Avila-Rios, Lilian Nogueira, Roshni Patel, Stephanie A. Azzopardi, Lion F.K. Uhl, Mohsan Saeed, Edgar E. Sevilla-Reyes, Marianna Agudelo, Kai-Hui Yao, Jovana Golijanin, Harry B. Gristick, Yu E. Lee, Arlene Hurley, Marina Caskey, Joy Pai, Thiago Oliveira, Elsio A. Wunder Jr., Gielson Sacramento, Nivison Nery Jr., Cibele Orge, Federico Costa, Mitermayer G. Reis, Neena M. Thomas, Thomas Eisenreich, Daniel M. Weinberger, Antonio R.P. de Almeida, Anthony P. West Jr., Charles M. Rice, Pamela J. Bjorkman, Gustavo Reyes-Teran, Albert I. Ko, Margaret R. MacDonald, Michel C. Nussenzweig, Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico, Cell, Volume 169, Issue 4, 4 May 2017, Pages 597-609.e11, ISSN 0092-8674, https://doi.org/10.1016/j.cell.2017.04.024.\n(http://www.sciencedirect.com/science/article/pii/S0092867417304750)","other_numbering_system":null,"funders":[{"agency":"NIH","grant_number":"U19AI111825-01"},{"agency":"NIH","grant_number":"UL1TR001866"},{"agency":"NIH","grant_number":"R01AI037526"},{"agency":"NIH","grant_number":"UM1AI100663"},{"agency":"NIH","grant_number":"U19AI111825"},{"agency":"NIH","grant_number":"UL1TR001866"},{"agency":"NIH","grant_number":"R01AI121207"},{"agency":"NIH","grant_number":"R01TW009504"},{"agency":"NIH","grant_number":"R25TW009338"},{"agency":"NIH","grant_number":"U01AI088752"},{"agency":"NIH","grant_number":"R01AI124690"},{"agency":"NIH","grant_number":"U19AI057229"},{"agency":"CCHI Opportunity Fund","grant_number":""},{"agency":"Rockefeller University Zika Fund","grant_number":""},{"agency":"Gordon and Betty Moore Foundation","grant_number":""},{"agency":"Department of Energy (DOE)","grant_number":""},{"agency":"Robertson Therapeutic Development Fund ","grant_number":""},{"agency":"Pew Latin American Fellows Program in the Biomedical Sciences","grant_number":""},{"agency":"Studienstiftung des deutschen Volkes","grant_number":""},{"agency":"Austrian Marshall Plan Foundation","grant_number":""},{"agency":"Consejo Nacional de Ciencia y Tecnología (CONACYT)","grant_number":""}],"collection":"CaltechAUTHORS","reviewer":"GP","local_group":null}